Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Thermo Fisher and QIAGEN Merge in Multi-Billion Deal
After a year hiatus from the acquisition trail, Thermo Fisher Scientific Inc. (NYSE: TMO) is back with a big deal. Earlier in March, the medical diagnostics company announced it was acquiring QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or 23.8x EBITDA and 7.5x revenue. QIAGEN provides sample-to-insight solutions that transform biological materials into molecular insights worldwide. It has more than 500,000 customers around the world in molecular diagnostics and life sciences. The terms include $43.64 per share in cash, a 23% premium to QIAGEN’s March 2, 2020 closing price, plus assumption of approximately $1.4 billion of net debt. This acquisition expands Thermo Fisher’s... Read More »
Home Health & Hospice Deal Flow Is Slow but Steady
Although Covid-19 has brought the U.S. economy to a halt over the past few weeks, there is still some healthcare M&A activity to be found, even in the Home Health & Hospice sector. So far for the first quarter, 16 deals have been made public, compared with 21 for Q1: 2019, according to our Deal Search Online database. It’s a 27% drop, but that’s a difference of five deals in extraordinarily different market conditions. We’ll take what we can get. Earlier in March, Charter Health Care Group, a portfolio company of Pharos Capital Group, acquired two hospice service providers from VeraCare Hospice, St. Luke’s Home Hospice LLC and Arizona Select Hospice LLC. St.... Read More »
Sanders Trust Buys Cobalt Rehab Hospital
Curahealth, a portfolio company of Nautic Partners, is selling the real estate assets of a rehabilitation hospital in New Orleans operated by its subsidiary, Cobalt Rehabilitation. Birmingham, Alabama-based The Sanders Trust will pay $29 million for the 60-bed inpatient rehab facility. The Cobalt Rehabilitation Hospital is a Class A, 65,345-square-foot facility located less than two miles from the new Louisiana State University and Veteran Administration hospitals that have approximately 1,000 acute care beds. Built in 2016, it serves a wide range of physical rehabilitation patients with conditions such as stroke, trauma, hip fracture, brain injuries, concussions, orthopedic and... Read More »
DXC Technology Divests State & Local HHS Business
When Mike Salvino took over as CEO of DXC Technology (NYSE: DXC) in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divesture of three of its non-core assets, which made up roughly 25% of the company’s revenue. One of those segments included its U.S. state and local health and human services business (HHS business), which DXC managed to divest last week to Veritas Capital Management LLC for $5 billion in cash. DXC’s HHS business is an end-to-end provider of technology solutions critical to the administration and operations of health programs. The business facilitates performance... Read More »
Blue Sprig Pediatrics Acquires ABA Providers
BlueSprig Pediatrics, with the backing of KKR & Co. (NYSE: KKR), has been an active player in the M&A field. Since BlueSprig was formed in October 2018, it has reported five behavioral health care transactions in three different states, according to our Deal Search Online database. Now it has a foothold in Florida. Last week the company announced its acquisition of Florida Autism Center and Fusion Autism Center for $120 million. Collectively called FAC, the group provides applied behavior analysis (ABA) therapy services treating children with autism spectrum disorder. This partnership will create a top-five national provider and the leading provider in the southern United States.... Read More »
Hospital M&A in 2019, by the Numbers
The hospital M&A market experienced some significant changes last year. In the United States, the rush to regionalize tapered off in 2019, after four years of multi-hospital transactions. The market for long-term acute care hospitals (LTACHs) was hopping, unfortunately driven by a couple of large bankruptcy proceedings. Deals either targeting or involving critical access hospitals (CAHs) ticked up slightly. And the divestiture programs of some for-profit chains began to wind down. In all, 74 U.S. hospital deals reached the definitive agreement or finalized stage in 2019, excluding foreign deals and those made by real estate investment trusts (REITs). The total is 12% more than the 66... Read More »
Retina Consultants of America Formed through PE-Backed Merger
And in one fell swoop, Webster Equity Partners has formed a major physician group. The private equity firm announced in early March that it is acquiring and merging Retina Consultants of Houston, Retina Group of Florida, Long Island Vitreoretinal Consultants, and Retinal Consultants Serving Northern California to form Retina Consultants of America (RCA). The platform has a $350 million investment to build on and will have EBITDA of $80 million and roughly 50 physicians, according to sources cited in PEHub. But tucked away in that price is a fifth transaction that we should hear about before the end of March. Further, Webster and RCA are planning to expand rapidly, adding more practices in... Read More »
Health Care M&A Deals, March 13, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets. eHealth Acquirer Target Price The... Read More »
Coronavirus Drags Down February M&A
Of course, we have to suggest that February’s abysmal deal volume—just 96 reported so far—may be the result of fears about the coronavirus. The reality is that the stock markets began swooning in late January, but managed to post a few bounce-back days here and there. They really didn’t tank for consecutive days until February 20, when the virus claimed its first U.S. victims and was spreading through communities. And with no sign of a coronavirus containment, it’s hard to say when the alarm will calm. We attended a few healthcare-related meetings in a couple of major cities during the final weeks of February. Attendance was high at every event. Only now are we hearing that... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
